Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Kindler syndrome (KS) is an autosomal recessive genodermatosis characterized by acral blistering in infancy, marked photosensitivity, progressive poikiloderma, skin atrophy, mucosal stenoses, and a heightened risk of squamous cell carcinoma. Biallelic loss-of-function variants in FERMT1, encoding kindlin-1—a focal adhesion protein linking integrins to the actin cytoskeleton—underlie KS pathogenesis (PMID:12668616).
Inheritance is strictly autosomal recessive, with over 150 affected individuals reported, including 62 patients in a multicenter cohort (PMID:21936020) and 91 adults in a retrospective study assessing squamous cell carcinoma risk (PMID:31340837). Segregation analysis in a large Palestinian pedigree demonstrated cosegregation of FERMT1 variants in 18 affected relatives (PMID:25515598).
The variant spectrum is dominated by nonsense, frameshift, and splice-site mutations predicted to abolish kindlin-1 expression. A recurrent nonsense allele, c.328C>T (p.Arg110Ter), has been identified homozygously in siblings with late diagnosis (PMID:20938162). Founder mutations such as c.676dup have been reported in Pakistani and Italian cohorts, facilitating targeted screening in these populations.
Loss of kindlin-1 impairs keratinocyte adhesion, spreading, and migration via disrupted integrin signaling. C-terminal truncations (e.g., exon-skipping due to c.1718+1G>A) produce nonfunctional proteins that escape degradation but fail to support focal adhesion stability (PMID:18652585; PMID:21146372). Kindlin-1–deficient keratinocytes show abnormal β1-integrin glycosylation and reduced surface expression, reversible upon wild-type FERMT1 complementation (PMID:23776470).
In vivo, zebrafish harboring a loss-of-function kindlin-1 mutation manifest epidermal fragility and fin rupturing, mirroring human KS and confirming a conserved adhesion defect (PMID:23549420). Rescue experiments with chemical chaperone sodium-phenylbutyrate in keratinocytes carrying a hypomorphic p.Arg100del allele restored kindlin-1 levels and cellular spreading, highlighting therapeutic potential (PMID:26827766).
No studies have refuted the FERMT1–KS association. Genotype–phenotype correlations suggest that missense and in-frame deletions may yield milder phenotypes, but overall clinical variability is influenced by environmental modifiers and potential genetic modifiers (PMID:21936020).
Definitive genetic and functional evidence support FERMT1 testing in patients with blistering, photosensitivity, and poikiloderma for accurate diagnosis, family counseling, and surveillance for skin cancer. Early molecular confirmation enables precision management and informs emerging chaperone-based therapies.
Gene–Disease AssociationDefinitiveOver 150 probands in multiple cohorts with robust segregation and functional concordance Genetic EvidenceStrongAutosomal recessive inheritance with loss-of-function variants in 153 probands across 10 families, including segregation in 18 relatives (PMID:25515598) Functional EvidenceStrongCellular and zebrafish models demonstrate impaired integrin-mediated adhesion and migration with rescue by wild-type FERMT1 or chaperone treatment (PMID:18652585; PMID:23549420; PMID:26827766) |